Anyone who treats ocular surface disease (OSD) recognizes the important role oral antibiotics play in therapy, especially in patients with meibomian gland dysfunction (MGD). Yet the existing evidence is insufficient to conclude the effectiveness of oral antibiotic therapy, according to a report published in Ophthalmology.
Antibiotic resistances are on the rise and as such, it behooves dermatologists to use antibiotics only when necessary and in combination with topical agents wherever possible in order to help stop this alarming trend.
The National Institute of Allergy and Infectious Diseases (NIAID) announced in January that it is funding 24 research projects, to the tune of about $5 million, to develop non-traditional therapeutics for bacterial infections. Learn more
Acute bacterial skin and skin structure infections are associated with unnecessary use of broad-spectrum antibiotics, leading to antibiotic resistance. Antimicrobial stewardship programs could be a very effective and useful approach to help stop the alarming trend of antibiotic resistance. Several strategies help optimize outcomes.